Details of the Drug

General Information of Drug (ID: DMPZ18B)

• Drug Name: RI-001
• Synonyms: RespImmune; RSV-IVIG; Respiratory syncytial virus infection therapy, ADMA Biologics

Indication

Disease Entry	ICD 11	Status	REF
Respiratory syncytial virus infection	1C80	Phase 2	[1]

• Cross-matching ID: TTD ID: D0Y5KL

References

• [1] ClinicalTrials.gov (NCT00632463) RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness. U.S. National Institutes of Health.